We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

About DREAM2

Enhancing surgical recovery

The DREAM application is a software that helps all healthcare professionals to follow and monitor patients throughout the care path: from preparation, to surgery up to the discharge and follow-up phase.

Through the prescription of activities and personalized questionnaires, the application helps patients prepare for surgery and monitor their progress during the recovery phase. It also allows healthcare professionals to record all patient-related information in detail, improving focus on the patient and facilitating the work of monitoring and recording information.

The DREAM application was developed to support the ERAS® protocol, which is based on the best available medical science to improve patients' post-operative results and reduce recovery times. Thanks to its information tracking and logging capabilities, the DREAM application helps ensure that the ERAS® protocol is followed correctly and that patients receive the best possible care.

What's New in the Latest Version 2.1.0

Last updated on Dec 31, 2023

- Implementati questionari certificati, tra cui:
1. EQ-5D-5L
2. Duke Activity Status Index
3. SF-36
4. Patient Health Engagement Model
- Risolti i problemi di disconnessione riscontrati da alcuni utenti

Translation Loading...

Additional APP Information

Latest Version

Request DREAM2 Update 2.1.0

Uploaded by

Toonne Radkittipoom

Requires Android

Android 5.1+

Available on

Get DREAM2 on Google Play

Show More

DREAM2 Screenshots

Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.